Page results
-
Charity Myeloma UK awards UCLH haematology team their Clinical Service Excellence Programme (CSEP) award in recognition of their outstanding care and unflagging dedication to patients living myeloma, an incurable blood cancer.
-
Information for the Camden Sickle Cell and Thalassaemia Service
-
Contact the Patient Advice and Liaison Service (PALS)
-
The spring/summer edition of Charity Matters is out now.
-
Dr Tim Yates has a particular interest in the management of refractory headache disorders, particularly chronic migraine, the trigeminal autonomic cephalalgias, and facial pain syndromes.
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
-
An international clinical trial testing a novel cancer immunotherapy which may prevent skin cancer from recurring has recruited its first patients at UCLH.
-
UCLH has continued to achieve excellent results in the National Inpatient Survey, with patients rating their overall care 8.7 out of 10. This is an improvement on our 2021 score and the highest score of any acute/combined trust in England.
-
UCLH is delighted that His Majesty King Charles III has accepted the patronages of University College Hospital and the Royal London Hospital for Integrated Medicine.
-
A team at UCLH, UCL and Mercedes-AMG High Performance Powertrains which developed a Continuous Positive Airway Pressure (CPAP) breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
File results
-
FOI/2023/0516 - Maternity management system
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0561 - Birthrate Plus
-
FOI/2023/0569 - Treatment for Ruxolitinib
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0559 - Patients admitted to hospital with dental distress